key: cord-0756593-8ol2x0hb authors: Jefferson, Larry S. title: Serious and lethal respiratory tract infections of viral etiology in children date: 2000-01-31 journal: Seminars in Pediatric Infectious Diseases DOI: 10.1053/spid.0110019 sha: 0f0904bcb01ab3e1221b1b8c453cb3489bac958e doc_id: 756593 cord_uid: 8ol2x0hb Abstract Viruses may lead to serious and lethal pulmonary infections in immunocompetent and immunocompromised children. Series of children with acute respiratory distress syndrome and series of children requiring extracorporeal membrane oxygenation, as well as reported series of nosocomial viral illness, offer an insight into the extent of serious viral disease documented in the medical literature. Series of children with specific viral respiratory illness also will be reviewed, as will the means of diagnosis in these groups of patients. Copyright © 2000 by W.B. Saunders Company shows the frequency and relative severity of the various viruses that cause pneumonia. 12 The purpose of this article is to review the literature regarding severe and lethal respiratory tract infections of viral etiologies in children. A review of pediatric series of adult respiratory distress syndrome (ARDS) and extracorporeal membrane oxygenation (ECMO) and an understanding of the viral etiologies of nosocomial infections in pediatric patients are places to start. In 1991, Timmons et al 13 described 44 children with adult respiratory distress syndrome (ARDS). In this series, an overall mortality rate of 75 percent was reported, with 1 of the 3 children with viral infection (all RSV) surviving. In a later series of 60 children with ARDS reported by Davis et al, 2 the overall mortality rate was 62 percent. These patients represented 2.7 percent of the admissions to their pediatric intensive care unit (PICU), 8 percent of the total days in the unit, and 33 percent of the PICU deaths during this 2-year study period. The authors reported that, for the group as a whole, the alveolar-arterial oxygenation tension difference (P (A-a) O 2 ) was the best early predictor of death. In determining mortality by etiology, the authors found that sepsis (n ϭ 22, 37% of patients), including two cases with viremia, was the most common cause. The 12 patients with ARDS secondary to a viral pneumonia represented 9 percent of the total of 135 patients admitted to their PICU with the diagnosis of viral pneumonia during this same period. The mortality rate in the children with a viral etiology for ARDS was 58 percent as compared with less than 1 percent of those with viral pneumonia that did not progress to ARDS. The viruses isolated in patients with ARDS included RSV, influenza, CMV, and measles; the frequency of each reflected its relative frequency in the 135 patients admitted with viral pneumonia. Because viral infections are recognized as the most common indication for pediatric ECMO, Meyer and Warner 3 reviewed the pediatric Extracorporeal Life Support Organization (ELSO) registry through December 1994 to report differences in outcomes of different viral etiologies. The viruses reported are listed in Table 2 , which shows RSV as the most common. Of the overall survival rate of 57 percent, the lowest survival rates were in patients who had adenoviral and herpes simplex virus infections (25% and 31%, respectively). Patients with RSV and CMV had the highest survival rate (67%). Of note, complications of ECMO were more common with specific viruses (Table 3 ). (See additional information regarding ECMO in the RSV section later.) Nosocomial viral disease often is a significant cause in serious and fatal viral pneumonias, particularly in children who are admitted because of underlying decreased immunocompetence (eg, after solid organ or bone marrow transplant, malignancies, Crohn disease) or in children with increased risk of pulmonary disease from acute (eg, measles) or chronic (eg, bronchopulmonary dysplasia, congential heart disease) illness. Viral etiologies of nosocomial lower respiratory infections in pediatric patients are reported to be up to 20 percent 13 and frequently are spread by pediatric hospital personnel. 14 Nosocomial adenoviral infection in patients admitted with measles disease may lead to death. 15 (See Adenovirus section below for additional information.) In a series of 95 children hospitalized with parainfluenza virus infections, noscomial infection occurred in 5 patients with bronchopulmonary dysplasia, 3 of whom died of progressive respiratory failure. 16 RSV has been shown by Hall and colleagues [17] [18] [19] to be a frequent source of nosocomial infections in the pediatric population, with a reported 100 percent infection rate for infants hospitalized longer than 4 weeks during a community outbreak. 18 In addition, nosocomial RSV infection has been associated with increased mortality in premature infants and in children with bronchopulmonary dysplasia or congenital heart disease. 20, 21 Despite the use of prophylactic [22] [23] [24] and therapeutic medical strategies, 25-28 RSV remains a significant cause of serious and fatal respiratory infections. In addition to being a significant cause of illness in children with underlying chronic illnesses, in an early series Krasinki 29 reported 3 of 7 pediatric patients dying, with 1 of the 7 surviving with chronic long disease. Moler et al 30 reported the RSV experience of the ELSO registry database as of June 1992. To that date, 53 pediatric patients with RSV infection had been placed on ECMO through the registry. Of 8 who had preexisting chronic lung or congenital heart disease, 6 survived. Of the total group, 27 of 53 (51%) survived. A backward stepwise logistic regression model of survival found nonsurvival to be associated with four factors: male gender, longer duration of mechanical ventilation before ECMO, peak inspiratory pressure, and a lower ratio of P a O 2 /F i O 2 . As stated above, nosocomial parainfluenza virus infections have been reported in patients with bronchopulmonary dysplasia, with three of five dying of progressive respiratory failure. 16 Delage et al 31 reported parainfluenza type 3 causing death after giant-cell pneumonia in two patients with severe combined immunodeficiency syndrome. The majority of influenza infections in children are self-limiting, without complications or sequelae, and have a reported mortality of 0.02 to 0.05 percent. [32] [33] [34] [35] Glenzen, 36 however, builds an argument that influenza deaths have not been apparent in excess mortality calculations for influenza epidemics. He notes that one explanation may be the reciprocal fluctuations in the intensity of epidemics caused by the group of viruses most likely to produce life-threatening respiratory infections in children (eg, RSV, influenza A and B, and parainfluenza 1 and 3) and that the risk of lower respiratory illness in young children remains relatively constant from one year to another. Deaths attributable to such illness would be detectable only under exceptional circumstances of a particular virulent and explosive influenza epidemic. CMV will be discussed in the sections below regarding Children Undergoing Thoracic Surgery and Bronchoalveolar Lavage. In 1990, Navarro et al 37 reported a clinicopathologic series of 71 children younger than 5 years (68% younger than 2 years) who died of acute lower respiratory tract infections in the Philip-pines. Measles was identified in 35 (49.9%) of these children. Of the 11 children in the series who died of isolated pneumonia without complicating or associated disease, 6 had a viral etiology. Similarly, in the 2 patients who had evidence of cardiac failure associated with pneumonia, both had measles. In this series, the odds ratio of a child with a bacterial acute lower respiratory tract infection dying with uncomplicated infection was significantly less than that for a child with a viral acute lower respiratory tract infection ( 39 Serious varicella infections and deaths usually are associated with encephalitis 51 ; however, serious and fatal pneumonia can develop, most often in immunocompromised children. 52, 53 A useful classification of children undergoing thoracic surgery is into groups of immunocompromised and immunocompetent hosts, for which the viral etiologies differ (Table 6 ). 54 The use of immunosuppressive medications in children undergoing heart, lung, or heart-lung transplantation affects cellular immunity, increasing the risk of these children developing an infection with one of the herpes viruses. On the other hand, in the immunocompetent patient who has viral pneumonia in the perioperative thoracic surgery period, the etiology is more likely to be a community-acquired or nosocomial virus. The viral agent may have been acquired and be incubating preoperatively, with the clinical manifestations of pneumonia only developing postoperatively, or the virus may be a true nosocomial infection. However, in the latter case, the specific etiologies parallel the viruses isolated in the community. 55 MacDonald et al 21 reported increased mortality in infants undergoing congenital heart surgery during RSV outbreaks in the community. Bork et al 7 reported a series of 128 infants who underwent cardiac transplantation, of whom 19 (15%) had CMV infections. Most of these children had symptoms within the first 2 to 3 months posttransplant. Fifteen patients had RSV infection, with infants younger than 6 months having a higher risk. Bridges et al 8 reported a series of pediatric patients undergoing lung or heart-lung transplantation. Sixteen patients underwent 19 transplants. Virus was identified in the transplanted lung on 29 occasions, with a frequency of 0.13 events per patient-month of follow-up. RSV was found 9 times in 8 patients. In 8 patients, the RSV infection was associated with relatively mild illness. However, in 1 patient, the RSV infection was associated with mortality, with RSV isolated from a tracheal aspirate in a patient dying of overwhelming Pseudomonas sepsis. Conversely, adenovirus was identified in 8 of 16 (50%) patients and was significantly associated with respiratory failure, leading to death or graft loss, and with a histologic diagnosis of obliterative bronchiolitis. Two cases of CMV were associated with significant respiratory disease; 1 patient recovered after receiving ganciclovir. In the second child, while receiving ganciclovir, CMV was identified concurrently with an adenoviral infection. This child required a second lung transplantation after severe respiratory failure. Both cases of parainfluenza disease also were associated with significant respiratory disease: one was associated with an RSV infection, and the other case led to obliterative bronchiolitis after an adenoviral infection. Other identified viruses, Epstein-Barr virus, herpes simplex virus, and influenza B were not associated with clinical respiratory illness. Bronchoalveolar lavage (BAL) is a useful technique to diagnose etiologies of lower respiratory tract infections in immunocompetent children, 4 in children with cancer, 5 and in children with pulmonary complications of bone marrow transplantation. 6 Rock 4 reported a series of 25 consecutive immunocompetent but significantly ill children with unexplained infiltrates on chest radiograph in whom 27 BAL procedures were performed. The diagnosis was made in 8 patients (30% yield), with 4 (50%) having a viral origin (2 RSV, 1 CMV, and 1 parainfluenza virus type 3). Stokes et al 5 Of these, 5 were positive for CMV, 2 for RSV, and 1 child had RSV plus parainfluenza virus isolated. Although the authors do not give data as to mortality by etiology, only 7 of 27 children (26%) were alive 90 days after BAL. Using polymerase chain (PCR) to amplify sequences of viruses known to cause viral infections in fixed-lung tissue of children dying of viral pneumonia, Akhtar et al 56 showed that PCR offers a rapid and sensitive method for the detection of viral genome from lung tissue. In a recent follow-up, the same group reported the successful use of tracheal aspirates as a substrate for the PCR to show viral genome in childhood pneumonia and myocarditis. Of significance were seven cases of myocarditis (Epstein-Barr virus) for which the viral genome amplified in cardiac biopsy specimens (Epstein-Barr virus) also was found in the tracheal aspirate. 57 The ease of obtaining tracheal samples, with less morbidity than with BAL or open-lung biopsy, renders this method a particularly exciting new tool for diagnosing children with severe and clinically unstable viral respiratory illness. Mortality rates and prognostic variables in children with adult respiratory distress syndrome Adult respiratory distress syndrome in children: Associated disease, clinical course, and predictors of death Extracorporeal life support for the treatment of viral pneumonia: Collective experience from the ELSO Registry The diagnostic utility of bronchoalveolar lavage in immunocompetent children with unexplained infiltrate on chest radiograph Role of flexible bronchoscopy in the diagnosis of pulmonary infiltrates in pediatric patients with cancer Bronchoscopy with bronchoalveolar lavage in the evaluation of pulmonary complications of bone marrow transplantation in children Infectious complications in infant heart transplantation Adenovirus infection in the lung results in graft failure after lung transplantation Viral pneumonia Pneumonia: An eleven-year study in a pediatric practice Problems in determining the etiology of communityacquired childhood pneumonia Textbook of Pediatric Infectious Diseases Epidemiology of nosocomial infection in pediatric patients The use of gowns and masks to control respiratory illness in pediatric hospital personnel Neonatal adenovirus infection: Four patients and review of the literature Clinical characteristics of parainfluenza virus infection in hospitalized children Modes of transmission of respiratory syncytial virus Nosocomial respiratory syncytial virus infections Neonatal respiratory syncytial virus infection Hospital Acquired Infection in the Pediatric Patient Respiratory syncytial viral infection in infants with congenital heart disease AAP: Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV Impact of palivizumab on expected costs of respiratory syncytial virus infection in preterm infants: Potential for savings Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection High dose-short duration ribavirin aerosol in children with suspected respiratory syncytial virus infection Respiratory system mechanics in patients receiving aerosolized ribavirin during mechanical ventilation for suspected respiratory syncytial viral infection Severe respiratory syncytial virus infection: Clinical features, nosocomial acquisition and outcome Predictors of outcome of severe respiratory syncytial virus-associated respiratory failure treated with extracorporeal membrane oxygenation Giant-cell pneumonia caused by parainfluenza virus Influenza-A infection in children Gastric 'flu' influenza B causing abdominal symptoms in children Influenzavirus A2 infections presenting with febrile convulsions and gastrointestinal symptoms in young children Type A2 influenza viral infections in children Consideration of the risk of influenza in children and indications for prophylaxis Clinicopathologic studies of children who die of acute lower respiratory tract infections: Mechanisms of death Respiratory failure complicating rubeola Laryngotracheobronchitis as a complication of measles during an urban epidemic Severe laryngotracheobronchitis complicating measles Severe complications of measles requiring intensive care in infants and young children Fatal adenovirus pneumonia Severe and fatal pneumonia in infants and young children associated with adenovirus infections Fatal pneumonia associated with adenovirus type 7 Extracorporeal membrane oxygenation: Its role in the survival of a child with adenoviral pneumonia and myocarditis The isolation of adenovirus type 7 from a fatal case of pneumonia and disseminated disease Neonatal infection caused by adenovirus type 7 A fatal case of inclusion body pneumonia in an infant infected with adenovirus type 3 Nosocomial adenovirus infection: Molecular epidemiology of an outbreak Fatal adenoviral (type 7) respiratory disease in neonates Age-specific risks of varicella complications Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine Varicella in children with cancer: Seventy-seven cases Viral pulmonary infections in thoracic and cardiovascular surgery Epidemiology and control of nosocomial viral infections PCR diagnosis of viral pneumonitis from fixed-lung tissue in children Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis